AST 120

Known as: AST-120 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2017
05101519852017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Reduced GFR in patients with CKD causes systemic accumulation of uremic toxins, which has been correlated with disease… (More)
Is this relevant?
2013
2013
BACKGROUND Chronic kidney disease (CKD) impairs intestinal barrier function which by allowing influx of noxious products causes… (More)
Is this relevant?
2013
2013
Accelerated cardiovascular disease is a frequent complication of CKD. Monocyte-mediated inflammation and adhesion of monocytes to… (More)
Is this relevant?
2009
2009
BACKGROUND Chronic kidney disease (CKD) is an important risk factor for cardiovascular disease (CVD). Increased oxidative stress… (More)
Is this relevant?
2008
2008
BACKGROUND/AIMS An oral adsorbent, AST-120, has been shown to retard the deterioration of renal function in patients with chronic… (More)
Is this relevant?
2007
2007
The effects of an oral adsorbent, AST-120, in chronic kidney disease (CKD) patients was evaluated by the 24-month dialysis-free… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND AST-120 (Kremezin; Kureha Chemical Industry Co Ltd, Tokyo, Japan) is an orally administered adsorbent showing… (More)
Is this relevant?
2006
2006
Advanced glycation end products (AGEs) are senescent macroprotein derivatives that are formed at an accelerated rate in patients… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2006
2006
BACKGROUND Using a rat model of renal failure with normal parathyroid hormone levels, we had demonstrated previously that bone… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1994
Highly Cited
1994
To determine the role of indoxyl sulfate in the progression of glomerular sclerosis, the serum level of indoxyl sulfate was… (More)
Is this relevant?